Company intelligence / Profile preview

Progenicyte

Los Angeles, California, United Statesprogenicyte.com ↗

Ownership: Private
Development stage: Other

Overview

Progenicyte is a biotechnology company focused on the development of regenerative medicine and stem cell-based therapies. The company utilizes a proprietary platform to isolate and differentiate stem cells for the treatment of various degenerative conditions, including neurological disorders and organ failure. Their research emphasizes the use of autologous and allogeneic cell sources to restore function in damaged tissues. Progenicyte aims to bridge the gap between laboratory discovery and clinical application through innovative cell engineering. The company's pipeline includes programs targeting Alzheimer's, Parkinson's, and spinal cord injuries.

Therapeutic areas: EndocrinologyNeurologyCardiovascularGastroenterology
Modalities: Stem cell therapyCell therapyInduced pluripotent stem cell derived therapy
Industry: Biotech

Beyond the preview

Go deeper on Progenicyte.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Progenicyte.